Kodiak AI, Inc. (KDK)
Live price chart, market sentiment, and community perspectives for Kodiak AI, Inc. (NASDAQ: KDK).
Live price chart, market sentiment, and community perspectives for Kodiak AI, Inc. (NASDAQ: KDK).
On our desk, KDK is splitting the market right down the middle. Sure, you have bulls pointing to a sub-$1.5B valuation and the narrative that they've cleared the hardest RandD milestones to scale fleet deployments toward the low hundreds. But looking at the SEC filings, the going concern warnings and a trailing FY2025 net loss of over $585 million cannot be hand-waved away. The $100 million PIPE financing announced in May 2026 buys them time, but the cash burn is brutal. If you're trading this, you are betting that software-style margins can materialize fast enough to outrun inevitable dilution and warrant exercises.
Watching the technicals and fundamental metrics from an analytics viewpoint, KDK is flashing multiple warning signs. Danelfin gives it a 4/10 Hold score with a negative probability advantage of -3.22% against the SandP 500 over the next 3 months, and AAII notes a very weak momentum score of 8 with a weighted four-quarter relative price strength of -26.80%. While a few analysts like Northland Securities have thrown out a Buy rating, the underlying financial data reveals a Piotroski F-Score of 1/9 and a tiny $3.8M in FY2025 revenue against massive operational overhead. It is a textbook high-volatility speculative play.
From an operational risk angle, evaluating Kodiak requires looking past the glossy press releases about California DMV testing permits and General Dynamics military alliances. The real protocol here is dissecting their deployment cadence versus regulatory bottlenecks. Autonomous trucking faces extreme friction state-by-state, and supply chain or retrofitting delays can crush timelines. When prepping a due diligence model for KDK, your focus shouldn't just be on the vehicle count targets for 2026 and 2027—it has to be heavily weighted on burn rate longevity and whether their customer adoption curve can survive without triggering deeply dilutive rescue capital.
Explore plasma cleansing, somatic organ swaps, and BCI.